FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:GBF1-NT5C2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: GBF1-NT5C2
FusionPDB ID: 32724
FusionGDB2.0 ID: 32724
HgeneTgene
Gene symbol

GBF1

NT5C2

Gene ID

80142

22978

Gene nameprostaglandin E synthase 25'-nucleotidase, cytosolic II
SynonymsC9orf15|GBF-1|GBF1|PGES2|mPGES-2GMP|NT5B|PNT5|SPG45|SPG65|cN-II
Cytomap

9q34.11

10q24.32-q24.33

Type of geneprotein-codingprotein-coding
Descriptionprostaglandin E synthase 2GATE-binding factor 1gamma-interferon-activated transcriptional element-binding factor 1mPGE synthase-2membrane-associated prostaglandin E synthase 2microsomal prostaglandin E synthase-2prostaglandin-H(2) E-isomerasecytosolic purine 5'-nucleotidase5'-nucleotidase (purine), cytosolic type BIMP-specific 5'-NTepididymis secretory sperm binding proteinspastic paraplegia 45 (autosomal recessive)
Modification date2020031320200313
UniProtAcc

Q92538

Main function of 5'-partner protein: FUNCTION: Guanine-nucleotide exchange factor (GEF) for members of the Arf family of small GTPases involved in trafficking in the early secretory pathway; its GEF activity initiates the coating of nascent vesicles via the localized generation of activated ARFs through replacement of GDP with GTP. Recruitment to cis-Golgi membranes requires membrane association of Arf-GDP and can be regulated by ARF1, ARF3, ARF4 and ARF5. Involved in the recruitment of the COPI coat complex to the endoplasmic reticulum exit sites (ERES), and the endoplasmic reticulum-Golgi intermediate (ERGIC) and cis-Golgi compartments which implicates ARF1 activation. Involved in COPI vesicle-dependent retrograde transport from the ERGIC and cis-Golgi compartments to the endoplasmic reticulum (ER) (PubMed:16926190, PubMed:17956946, PubMed:18003980, PubMed:12047556, PubMed:12808027, PubMed:19039328, PubMed:24213530). Involved in the trans-Golgi network recruitment of GGA1, GGA2, GGA3, BIG1, BIG2, and the AP-1 adapter protein complex related to chlathrin-dependent transport; the function requires its GEF activity (probably at least in part on ARF4 and ARF5) (PubMed:23386609). Has GEF activity towards ARF1 (PubMed:15616190). Has in vitro GEF activity towards ARF5 (By similarity). Involved in the processing of PSAP (PubMed:17666033). Required for the assembly of the Golgi apparatus (PubMed:12808027, PubMed:18003980). The AMPK-phosphorylated form is involved in Golgi disassembly during mitotis and under stress conditions (PubMed:18063581, PubMed:23418352). May be involved in the COPI vesicle-dependent recruitment of PNPLA2 to lipid droplets; however, this function is under debate (PubMed:19461073, PubMed:22185782). In neutrophils, involved in G protein-coupled receptor (GPCR)-mediated chemotaxis und superoxide production. Proposed to be recruited by phosphatidylinositol-phosphates generated upon GPCR stimulation to the leading edge where it recruits and activates ARF1, and is involved in recruitment of GIT2 and the NADPH oxidase complex (PubMed:22573891). Plays a role in maintaining mitochondrial morphology (PubMed:25190516). {ECO:0000250|UniProtKB:Q9R1D7, ECO:0000269|PubMed:12047556, ECO:0000269|PubMed:12808027, ECO:0000269|PubMed:15616190, ECO:0000269|PubMed:16926190, ECO:0000269|PubMed:17666033, ECO:0000269|PubMed:17956946, ECO:0000269|PubMed:18003980, ECO:0000269|PubMed:18063581, ECO:0000269|PubMed:19461073, ECO:0000269|PubMed:22185782, ECO:0000269|PubMed:22573891, ECO:0000269|PubMed:23386609, ECO:0000269|PubMed:23418352, ECO:0000269|PubMed:24213530, ECO:0000269|PubMed:25190516, ECO:0000305|PubMed:19039328, ECO:0000305|PubMed:22573891}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000369983, ENST00000476019, 
ENST00000369857, ENST00000423468, 
ENST00000470299, ENST00000343289, 
ENST00000404739, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score15 X 10 X 9=13509 X 12 X 4=432
# samples 1612
** MAII scorelog2(16/1350*10)=-3.07681559705083
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(12/432*10)=-1.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: GBF1 [Title/Abstract] AND NT5C2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: GBF1 [Title/Abstract] AND NT5C2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)GBF1(104019873)-NT5C2(104866463), # samples:3
Anticipated loss of major functional domain due to fusion event.GBF1-NT5C2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
GBF1-NT5C2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
GBF1-NT5C2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
GBF1-NT5C2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:104019873/chr10:104866463)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across GBF1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NT5C2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000369983GBF1chr10104019873+ENST00000343289NT5C2chr10104866463-54234232601933557
ENST00000369983GBF1chr10104019873+ENST00000404739NT5C2chr10104866463-35894232601933557

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000369983ENST00000343289GBF1chr10104019873+NT5C2chr10104866463-0.0006202290.99937975
ENST00000369983ENST00000404739GBF1chr10104019873+NT5C2chr10104866463-0.0009672530.99903274

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for GBF1-NT5C2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
GBF1chr10104019873NT5C2chr1010486646342354SFGHLKEVLNSITVYKSPEYESLGFE

Top

Potential FusionNeoAntigen Information of GBF1-NT5C2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GBF1-NT5C2_104019873_104866463.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:01VLNSITVY0.99950.7316715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:25TVYKSPEY0.99880.9041220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:25VLNSITVY0.99760.7606715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:02TVYKSPEY0.99660.91531220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:02VLNSITVY0.99380.7795715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B45:01KEVLNSITV0.99860.7162514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B50:02KEVLNSITV0.99850.5469514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:25ITVYKSPEY0.9980.80951120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:02ITVYKSPEY0.99050.82251120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:01ITVYKSPEY0.98920.77291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:17ITVYKSPEY0.9890.65251120
GBF1-NT5C2chr10104019873chr10104866463423HLA-A30:08VLNSITVYK0.98050.5841716
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:08EVLNSITVY0.97780.6933615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:02EVLNSITVY0.96570.7459615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:01EVLNSITVY0.94990.6658615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:25EVLNSITVY0.94440.7201615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B47:01KEVLNSITV0.82280.5252514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B41:01KEVLNSITV0.60180.8562514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B50:01KEVLNSITV0.48010.5796514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B39:13KEVLNSITV0.480.8448514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B44:03KEVLNSITVY0.99710.8847515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:01KEVLNSITVY0.98960.839515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:25KEVLNSITVY0.9250.8222515
GBF1-NT5C2chr10104019873chr10104866463423HLA-C15:04TVYKSPEY0.98780.81691220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:31TVYKSPEY0.9870.89161220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:05VLNSITVY0.97510.5673715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:21ITVYKSPEY0.98940.79361120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:05ITVYKSPEY0.96660.71611120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:21EVLNSITVY0.96490.7255615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:31EVLNSITVY0.95010.6273615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:07ITVYKSPEY0.93590.52931120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:31ITVYKSPEY0.92130.72991120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:05EVLNSITVY0.90950.6138615
GBF1-NT5C2chr10104019873chr10104866463423HLA-C15:04ITVYKSPEY0.75020.82891120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B39:08KEVLNSITV0.50030.7403514
GBF1-NT5C2chr10104019873chr10104866463423HLA-C03:14ITVYKSPEY0.31890.96271120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C12:12ITVYKSPEY0.15620.90171120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C12:04ITVYKSPEY0.05620.9881120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C06:03ITVYKSPEY0.05180.98941120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:07KEVLNSITVY0.96910.5378515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:05KEVLNSITVY0.83580.7495515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:50VLNSITVY0.99950.8146715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:33VLNSITVY0.99950.7316715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:27VLNSITVY0.99950.7414715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:34VLNSITVY0.99950.7316715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:125VLNSITVY0.99950.7316715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:135VLNSITVY0.99930.742715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:35VLNSITVY0.99920.6637715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:39TVYKSPEY0.99850.83571220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:12VLNSITVY0.99840.6898715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:50TVYKSPEY0.9980.80691220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:11TVYKSPEY0.99730.84921220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:39VLNSITVY0.99690.5946715
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:43TVYKSPEY0.99610.85611220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:11TVYKSPEY0.99480.90561220
GBF1-NT5C2chr10104019873chr10104866463423HLA-C15:09TVYKSPEY0.98780.81691220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:20TVYKSPEY0.98140.92671220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:20VLNSITVY0.97730.6819715
GBF1-NT5C2chr10104019873chr10104866463423HLA-C03:02TVYKSPEY0.96130.96521220
GBF1-NT5C2chr10104019873chr10104866463423HLA-C12:02TVYKSPEY0.93620.92671220
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:39ITVYKSPEY0.99780.63831120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B40:04KEVLNSITV0.99690.6336514
GBF1-NT5C2chr10104019873chr10104866463423HLA-A25:01EVLNSITVY0.99680.6456615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:33ITVYKSPEY0.98920.77291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:125ITVYKSPEY0.98920.77291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:34ITVYKSPEY0.98920.77291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:27ITVYKSPEY0.98910.80181120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:135ITVYKSPEY0.98710.76281120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:11ITVYKSPEY0.98490.77471120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:50ITVYKSPEY0.98410.82291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-A30:01VLNSITVYK0.97920.6849716
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:08ITVYKSPEY0.97810.68291120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:11ITVYKSPEY0.97810.68911120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:20ITVYKSPEY0.96940.82621120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:11EVLNSITVY0.96610.7193615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:43ITVYKSPEY0.96010.67321120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:23EVLNSITVY0.95060.6531615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:77EVLNSITVY0.94990.6658615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:28ITVYKSPEY0.9490.8171120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:12ITVYKSPEY0.94850.77931120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:20EVLNSITVY0.94410.6937615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:39EVLNSITVY0.93520.5849615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:35ITVYKSPEY0.92240.73471120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:20ITVYKSPEY0.91280.82341120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:20EVLNSITVY0.90450.6918615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:28EVLNSITVY0.87220.6792615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:27EVLNSITVY0.86880.7213615
GBF1-NT5C2chr10104019873chr10104866463423HLA-C03:02ITVYKSPEY0.86030.93541120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:24EVLNSITVY0.85750.7023615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:11EVLNSITVY0.84590.6659615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:08EVLNSITVY0.8420.6595615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:43EVLNSITVY0.82460.6641615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:50EVLNSITVY0.79620.7919615
GBF1-NT5C2chr10104019873chr10104866463423HLA-C15:09ITVYKSPEY0.75020.82891120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B41:03KEVLNSITV0.70940.5262514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:17EVLNSITVY0.69220.5056615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:30EVLNSITVY0.69220.5056615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:12EVLNSITVY0.68880.7278615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B50:05KEVLNSITV0.48010.5796514
GBF1-NT5C2chr10104019873chr10104866463423HLA-B50:04KEVLNSITV0.48010.5796514
GBF1-NT5C2chr10104019873chr10104866463423HLA-C12:02ITVYKSPEY0.39540.94521120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C16:04ITVYKSPEY0.38960.96381120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B18:04EVLNSITVY0.37270.6866615
GBF1-NT5C2chr10104019873chr10104866463423HLA-B39:02KEVLNSITV0.29630.8617514
GBF1-NT5C2chr10104019873chr10104866463423HLA-C16:01ITVYKSPEY0.2690.95941120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C12:03ITVYKSPEY0.2180.96581120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B18:07EVLNSITVY0.11650.6313615
GBF1-NT5C2chr10104019873chr10104866463423HLA-C16:02ITVYKSPEY0.05070.97851120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C02:10ITVYKSPEY0.00180.95511120
GBF1-NT5C2chr10104019873chr10104866463423HLA-C02:02ITVYKSPEY0.00180.95511120
GBF1-NT5C2chr10104019873chr10104866463423HLA-B44:13KEVLNSITVY0.99710.8847515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B44:07KEVLNSITVY0.99710.8847515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B44:26KEVLNSITVY0.99710.8847515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:33KEVLNSITVY0.98960.839515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:34KEVLNSITVY0.98960.839515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:125KEVLNSITVY0.98960.839515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:27KEVLNSITVY0.98920.8156515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:135KEVLNSITVY0.98890.8391515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:50KEVLNSITVY0.98630.8548515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:12KEVLNSITVY0.97270.8121515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:35KEVLNSITVY0.97270.7669515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:39KEVLNSITVY0.92540.6947515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B18:11KEVLNSITVY0.91940.795515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:53KEVLNSITVY0.91650.801515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:54KEVLNSITVY0.83920.7798515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B15:20KEVLNSITVY0.83660.8217515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B35:28KEVLNSITVY0.81870.8129515
GBF1-NT5C2chr10104019873chr10104866463423HLA-B48:02KEVLNSITVY0.750.7851515
GBF1-NT5C2chr10104019873chr10104866463423HLA-A02:03HLKEVLNSITV0.99960.7607314

Top

Potential FusionNeoAntigen Information of GBF1-NT5C2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GBF1-NT5C2_104019873_104866463.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0415KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0415LKEVLNSITVYKSPE419
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0427KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0436KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0436LKEVLNSITVYKSPE419
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0453KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0453LKEVLNSITVYKSPE419
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0455KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0458KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0458LKEVLNSITVYKSPE419
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0465KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0478KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-0478LKEVLNSITVYKSPE419
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1002KEVLNSITVYKSPEY520
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1201VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1203VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1203LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1205VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1206VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1207VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1208VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1208LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1210VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1214VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1217VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1501VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1501LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1501NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1501EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1502VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1502LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1503VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1503LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1503NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1503EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1504VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1504LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1504NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1505VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1505LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1505NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1505EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1506VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1506LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1506NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1506EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1507VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1507LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1507NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1507EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1508VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1508LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1509VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1509LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1509NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1509EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1510VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1510LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1510NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1510EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1511VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1511LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1512VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1512LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1512EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1512NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1513VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1513LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1513NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1513EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1514VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1514LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1516VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1516LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1516NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1516EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1518VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1518LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1518NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1518EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1519VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1519LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1520VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1520LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1520NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1520EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1521VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1521LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1521NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1521EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1522VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1522LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1522NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1522EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1523VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1523LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1524VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1524LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1524NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1524EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1525VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1525LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1526VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1526LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1528VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1528LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1528NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1528EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1529VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1529LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1529EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1529NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1530VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1530LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1530NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1530EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1531VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1531LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1532VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1532LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1532NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1532EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1533VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1533LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1533NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1533EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1535VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1535LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1535NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1535EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1536VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1536LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1536NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1536EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1537VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1537LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1537NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1537EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1538VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1538LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1539VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1539LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1540VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1540LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1540NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1540EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1541VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1541LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1541NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1541EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1542VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1542LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1542NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1542EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1543VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1543LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1543NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1543EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1544VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1544LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1545VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1545LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1545NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1545EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1546VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1546LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1546NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1546EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1547VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1547LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1548VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1548LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1548NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1548EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1549VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1549LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1549NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB1-1549EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0106VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0106LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0106EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0106NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0202VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0202LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0202NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0202EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0203VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0203LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0204VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0204LNSITVYKSPEYESL823
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0204EVLNSITVYKSPEYE621
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0204NSITVYKSPEYESLG924
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0205VLNSITVYKSPEYES722
GBF1-NT5C2chr10104019873chr10104866463423DRB5-0205LNSITVYKSPEYESL823

Top

Fusion breakpoint peptide structures of GBF1-NT5C2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2227EVLNSITVYKSPEYGBF1NT5C2chr10104019873chr10104866463423

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of GBF1-NT5C2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2227EVLNSITVYKSPEY-6.80686-6.92026
HLA-B14:023BVN2227EVLNSITVYKSPEY-5.01234-6.04764
HLA-B52:013W392227EVLNSITVYKSPEY-6.71251-6.82591
HLA-B52:013W392227EVLNSITVYKSPEY-4.13165-5.16695
HLA-A11:014UQ22227EVLNSITVYKSPEY-4.31699-4.43039
HLA-A11:014UQ22227EVLNSITVYKSPEY-4.19959-5.23489
HLA-A24:025HGA2227EVLNSITVYKSPEY-7.74913-7.86253
HLA-A24:025HGA2227EVLNSITVYKSPEY-5.75888-6.79418
HLA-B27:036PZ52227EVLNSITVYKSPEY1000110000
HLA-B44:053DX82227EVLNSITVYKSPEY-4.89721-5.01061
HLA-B44:053DX82227EVLNSITVYKSPEY-3.74482-4.78012
HLA-A02:016TDR2227EVLNSITVYKSPEY-5.01451-6.04981

Top

Vaccine Design for the FusionNeoAntigens of GBF1-NT5C2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
GBF1-NT5C2chr10104019873chr101048664631120ITVYKSPEYTAACAGTGTACAAGTCCCCAGAGTATG
GBF1-NT5C2chr10104019873chr101048664631220TVYKSPEYCAGTGTACAAGTCCCCAGAGTATG
GBF1-NT5C2chr10104019873chr10104866463314HLKEVLNSITVATCTAAAGGAGGTTTTAAACAGTATAACAGTGT
GBF1-NT5C2chr10104019873chr10104866463514KEVLNSITVAGGAGGTTTTAAACAGTATAACAGTGT
GBF1-NT5C2chr10104019873chr10104866463515KEVLNSITVYAGGAGGTTTTAAACAGTATAACAGTGTACA
GBF1-NT5C2chr10104019873chr10104866463615EVLNSITVYAGGTTTTAAACAGTATAACAGTGTACA
GBF1-NT5C2chr10104019873chr10104866463715VLNSITVYTTTTAAACAGTATAACAGTGTACA
GBF1-NT5C2chr10104019873chr10104866463716VLNSITVYKTTTTAAACAGTATAACAGTGTACAAGT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
GBF1-NT5C2chr10104019873chr10104866463419LKEVLNSITVYKSPETAAAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGT
GBF1-NT5C2chr10104019873chr10104866463520KEVLNSITVYKSPEYAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATG
GBF1-NT5C2chr10104019873chr10104866463621EVLNSITVYKSPEYEAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGT
GBF1-NT5C2chr10104019873chr10104866463722VLNSITVYKSPEYESTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGTCCC
GBF1-NT5C2chr10104019873chr10104866463823LNSITVYKSPEYESLTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGTCCCTTG
GBF1-NT5C2chr10104019873chr10104866463924NSITVYKSPEYESLGACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGTCCCTTGGTT

Top

Information of the samples that have these potential fusion neoantigens of GBF1-NT5C2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
COADGBF1-NT5C2chr10104019873ENST00000369983chr10104866463ENST00000343289TCGA-CA-5254-01A

Top

Potential target of CAR-T therapy development for GBF1-NT5C2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to GBF1-NT5C2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to GBF1-NT5C2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource